Top Section/Ad
Top Section/Ad
Most recent
Sfr4.9bn trade is largest European ECM deal since National Grid’s £7bn rights issue in 2024
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
More articles/Ad
More articles/Ad
More articles
-
Kantonsspital Baden satisfies investor demand for long paper with pick-up -
Bankers say a lack of investor confidence makes bigger deals more challenging
-
The Saudi drug maker's IPO is the first major flotation in the country this year
-
Fourth biggest bond ever needed new pricing approach to work
-
2023 has been a slow year for Saudi Arabia's IPO market
-
In a block trade, GSK sold 2.6% of its former joint venture with Pfizer
